Navigation Links
KV Pharmaceutical Announces Stockholder Action to Amend By-Laws is Invalid
Date:8/7/2009

ST. LOUIS, Aug. 7 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE: KVa/KVb) (the "Company") today announced that the Company notified certain owners of the Company's Class A and Class B Common Stock, as further described below (the "Reporting Persons"), that the stockholder action by written consent purported to have been taken by such Reporting Persons on August 5, 2009 does not comply with the requirements of the Company's By-Laws and is therefore invalid and not effective.

Specifically, on August 5, 2009, the Reporting Persons filed with the U.S. Securities and Exchange Commission (the "SEC") a Schedule 13D disclosing their beneficial ownership of the Company's Class A Common Stock and a Schedule 13D disclosing their beneficial ownership of the Company's Class B Common Stock. Such Reporting Persons included Marc S. Hermelin, the Company's former chief executive officer and a current member of the Company's Board of Directors (the "Board"), David S. Hermelin, a member of the Board and the son of Mr. Marc S. Hermelin, and certain other persons, including various family members and trusts associated with Mr. Marc S. Hermelin.

The Schedules 13D filed by the Reporting Persons, which are available on the SEC's EDGAR website at www.sec.gov, also disclosed that such Reporting Persons have executed and delivered to the Company a purported action by written consent of stockholders relating to the adoption of certain amendments to the Company's By-Laws. A copy of such stockholder written consent was filed as an exhibit to each Schedule 13D. The Company received an executed copy of such stockholder written consent on August 5, 2009.

On August 7, 2009, the Company notified the Reporting Persons by letter that, because the Reporting Persons have failed to comply with Article II, Section 12 of the Company's By-Laws (requiring a stockholder seeking to act by written consent
'/>"/>

SOURCE KV Pharmaceutical Company
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results
2. Onyx Pharmaceuticals Announces Pricing of Concurrent Offerings of Four Million Shares of Common Stock and $200 Million Principal Amount of Convertible Senior Notes
3. Vanda Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 10, 2009
4. Data Published in Cell Stem Cell Demonstrates Potent Anti-Cancer Activity for OncoMed Pharmaceuticals Lead Antibody
5. Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
6. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
7. Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results
8. ADVENTRX Pharmaceuticals Announces Financing
9. Idenix Pharmaceuticals Prices Underwritten Offering of Common Stock
10. Optimer Pharmaceuticals Reports Second Quarter 2009 Financial Results
11. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Radezolid in Community-Acquired Pneumonia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ov.25/PRNewswire/--ResearchTrianglePark-basedCnano...mentwaterpurificationsystemNanoPure(TM)developedfr...terSupply,Hon.MinisterViswarupandotherleadersinHyd...stituteofTechnology(IIT)Kanpur,confirmedthatthemaj...insthatcanbeextremelyhazardoustohumanhealth. ,,...
(Date:11/25/2009).../PRNewswire/--BiotechfirmReplikinsLtd.,whichhasana...roughtheprediction,outbreak,andprogressofthecurren...sisofthevirus.Thenewdatashowsthatthelethalityofthe...d.4.5)duringthevirus,scurrentoutbreakinthespringof....1).TheH1N1virus,infectivitycount,however,remainsi...
(Date:11/25/2009)... Ambassador to Speak at Economic Club of Canad...s) November 25, 2009 -- Ambassador to Speak at Eco...French Ambassador for International Investment, an...,To view a biography of David Appia go to www.inv... available to meet with press to discuss recent pr...
(Date:11/25/2009)...RATON,Fla.,Nov.25/PRNewswire/--Formanybusinesses,2...on,slargestandfastestgrowingnetworkofexpertphysici...oidenticalhormones has grownthenumberof physicia...cians -andisinprogresstoaddmorephysician-ownedcent..., Inthepastyear ,BodyLogicMDhasopened13newbioid...
Breaking Biology Technology:North Carolina-based Cnanoz Unveils NanoPure(TM) to Government Leaders in Hyderabad, India 2Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4French Ambassador for International Investment to Visit Toronto December 11 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3
...e U.S. Food and Drug,Administration (FDA) today ap...t of schizophrenia in adolescents ages 13-17 and f...iated with manic or mixed episodes of,bipolar I di...is approval is based on studies involving more tha...schizophrenia and 160 children and,adolescents, ag...
...hua-PRNewswire-FirstCall/ --,China-Biotics, Inc. (...ompany"), a leading Chinese firm specializing in t...d distribution of probiotics products,announced to...iry & Food,Co., Ltd. ("Bright Dairy") (SSE: 600597...m products for the next three years. China-Biotic...
... HealthWave Members with Valuable Local ... 22 UniCare Health Plan of Kansas,Inc. today anno...Center,(CRC) in Topeka, Kansas. With many of Kansa...he CRC will provide access to outreach services, h...pecialized services for,HealthWave members and the...
Other Biology Technology:FDA Approves RISPERDAL(R) to Treat Adolescents with Schizophrenia and Children and Adolescents with Bipolar Mania 2FDA Approves RISPERDAL(R) to Treat Adolescents with Schizophrenia and Children and Adolescents with Bipolar Mania 3China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd. 2China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd. 3UniCare Unveils Community Resource Center in Topeka to Serve Medicaid Enrollees 2
(Date:11/23/2009)...unprecedented detail how the ribosome interacts wi...ide them toward their destination in biological ce...fitting (MDFF) to examine the interaction of the r... The first study, in Proceedings of the National...ling between the ribosome and an elongation factor...
(Date:11/23/2009)...ries about the multiple health benefits of vitamin...ient, increased awareness of the huge numbers of p...d even led to an appreciation of it as "nature,s a...of your immune system to prevention of heart disea...is now seen as one of the most critical nutrients ...
(Date:11/23/2009)... , , , , , , , ... Marshall, from the Environment Department at the ...nyongia magomberae and his wider work in Tanzania...tion. , , , , , , , ..., , , , A new species of chameleon has be...
Breaking Biology News(10 mins):Computational microscope peers into the working ribosome 2Computational microscope peers into the working ribosome 3Multiple health concerns surface as winter, vitamin D deficiences arrive 2Multiple health concerns surface as winter, vitamin D deficiences arrive 3New chameleon species discovered in East Africa 2New chameleon species discovered in East Africa 3Integrated Medical Systems Receives 243 25 Million from the U S Army for Worlds First Suitcase Intensive Care Unit 54144 1Integrated Medical Systems Receives 243 25 Million from the U S Army for Worlds First Suitcase Intensive Care Unit 54144 2Integrated Medical Systems Receives 243 25 Million from the U S Army for Worlds First Suitcase Intensive Care Unit 54144 3Spectrum Announces New Distribution of AC Powered Tool for Crimping and Decapping of Laboratory Vials The CRIMPenstein 26amp 3B 238482 3B 13482 1Spectrum Announces New Distribution of AC Powered Tool for Crimping and Decapping of Laboratory Vials The CRIMPenstein 26amp 3B 238482 3B 13482 2EyeCare America Works to Prevent Blindness Caused by Cataracts 54141 1EyeCare America Works to Prevent Blindness Caused by Cataracts 54141 2EyeCare America Works to Prevent Blindness Caused by Cataracts 54141 3
...nknown human health and environmental impacts of n...an for the public, according to a new report publi...hnology. , The new report was based on a national...pling of 363 leading U.S. nanotechnology scientist...st insight into a technology with enormous potenti...
... MIT researchers have found that the children of ...h arsenic during their pregnancies harbored gene e...r diseases later in life. In addition to establish...l exposures, the new study also provides a possibl... of arsenic contamination. , This is the first ti...
...rchers, led by the University of Sheffield and Que...plants protect their leaves from damage by sunligh...ew findings, which have been published in Nature, ...o the threat of global warming and for helping man...n plants relies upon the efficient collection of s...
Other Biology News:Nanotech's health, environment impacts worry scientists 2Nanotech's health, environment impacts worry scientists 3MIT: Prenatal arsenic exposure detected in newborns 2MIT: Prenatal arsenic exposure detected in newborns 3Scientists unravel plants' natural defenses 2
Rabbit Anti-Human Rab1A Antibody, Unconjugated from Spring Bioscience
Rat Anti-acetyl Salicylic Acid Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-DcR1 Monoclonal Antibody, Phycoerythrin Conjugated, Clone DJR3 from Abcam
Chicken Anti-GBL Polyclonal Antibody, Unconjugated from ProSci, Inc
Biology Products: